Capromorelin

Drug profile

Key facts

Capromorelin is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including Ghsr and GHSR.

• Molecular targets: Ghsr and GHSR (2 listed in DrugCentral).
• Molecular formula: C28H35N5O4; molecular weight 505.62 g/mol.

Mechanism & targets

Molecular targets (2)

Target	Gene	Action	Activity
Growth hormone secretagogue receptor type 1	Ghsr	unknown	EC50 8.52
Growth hormone secretagogue receptor type 1	GHSR	unknown	Ki 8.15

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
—	FDA	—	—

Chemical structure

• Molecular formula: C₂₈H₃₅N₅O₄
• Molecular weight: 505.62 g/mol
• CAS number: 193273-66-4
• InChIKey: KVLLHLWBPNCVNR-SKCUWOTOSA-N
• PubChem CID: 216208

CN1N=C2CCN(C[C@@]2(CC3=CC=CC=C3)C1=O)C(=O)[C@@H](COCC4=CC=CC=C4)NC(=O)C(C)(C)N

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Capromorelin work?

Its molecular targets in DrugCentral include Ghsr and GHSR.

What is the chemical formula of Capromorelin?

Capromorelin has the molecular formula C28H35N5O4 and a molecular weight of 505.62 g/mol.

Sources

• DrugCentral drug card 5656 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL113313 — compound record and bioactivity
• PubChem CID 216208 — chemical identifiers
• DrugBank DB15205 — drug record
• FDA UNII 0MQ44VUN84 — substance identity
• DailyMed: FDA labels for Capromorelin — current prescribing information (label search)
• UniProt Q92847 (GHSR) — target protein

How this page is built: methodology · editorial policy & corrections.